Clinical Trial Update: Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intracavitary cisplatin-fibrin localized chemotherapy after pleurectomy/decortication or extrapleural pneumonectomy for ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• cisplatin-fibrin intracavitary chemotherapy (cisplatin-fibrin)

Snippet

Sponsor: University of Zurich | Conditions: Malignant Pleural Mesothelioma | Phase 1, Phase 2 | Status: COMPLETED